These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8652852)
21. Primitive hematopoietic progenitor cells are present in peripheral blood autografts. Tong J; Gianni AM; Siena S; Srour EF; Bregni M; Hoffman R Blood Cells; 1994; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339 [TBL] [Abstract][Full Text] [Related]
22. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381 [TBL] [Abstract][Full Text] [Related]
23. Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma. Corato A; Ambrosetti A; Rossi B; Vincenzi C; Lambiase A; Perona G; Pizzolo G; de Wynter E; Nadali G J Hematother Stem Cell Res; 2000 Oct; 9(5):673-82. PubMed ID: 11091491 [TBL] [Abstract][Full Text] [Related]
24. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558 [TBL] [Abstract][Full Text] [Related]
25. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. Bacigalupo A; Van Lint MT; Valbonesi M; Lercari G; Carlier P; Lamparelli T; Gualandi F; Occhini D; Bregante S; Valeriani A; Piaggio G; Pitto A; Benvenuto F; Figari O; De Stefano G; Caimo A; Sessarego M Blood; 1996 Jul; 88(1):353-7. PubMed ID: 8704195 [TBL] [Abstract][Full Text] [Related]
26. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260 [TBL] [Abstract][Full Text] [Related]
27. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Neben S; Marcus K; Mauch P Blood; 1993 Apr; 81(7):1960-7. PubMed ID: 7681707 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of a novel automated protocol for the collection of peripheral blood stem cells mobilized with chemotherapy or chemotherapy plus G-CSF using the Fresenius AS104 cell separator. Pierelli L; Menichella G; Paoloni A; Vittori M; Foddai ML; Serafini R; Rumi C; Mitschulat H; Rossi PL; Scambia G J Hematother; 1993; 2(2):145-53. PubMed ID: 7522877 [TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of cobblestone area-forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay. Schrezenmeier H; Jenal M; Herrmann F; Heimpel H; Raghavachar A Blood; 1996 Dec; 88(12):4474-80. PubMed ID: 8977239 [TBL] [Abstract][Full Text] [Related]
30. Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood. Roecklein BA; Reems J; Rowley S; Torok-Storb B Biol Blood Marrow Transplant; 1998; 4(2):61-8. PubMed ID: 9763108 [TBL] [Abstract][Full Text] [Related]
31. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Koumakis G; Vassilomanolakis M; Hatzichristou H; Barbounis V; Filis J; Papanastasiou K; Moraki M; Kritsioti M; Plataniotis G; Stamatelou M; Efremidis AP Bone Marrow Transplant; 1996 Dec; 18(6):1065-72. PubMed ID: 8971374 [TBL] [Abstract][Full Text] [Related]
32. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643 [TBL] [Abstract][Full Text] [Related]
33. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells. Knudsen LM; Gaarsdal E; Jensen L; Nielsen KJ; Nikolaisen K; Johnsen HE J Hematother; 1996 Aug; 5(4):399-406. PubMed ID: 8877715 [TBL] [Abstract][Full Text] [Related]
34. Both cycling and noncycling primitive progenitors continue to be mobilized into the circulation during the leukapheresis of patients pretreated with chemotherapy and G-CSF. Ponchio L; Eaves C; Hogge D; Perotti C; Torretta L; Cerani P; Salvaneschi L; Ascari E; Cazzola M Br J Haematol; 1997 Nov; 99(2):394-402. PubMed ID: 9375761 [TBL] [Abstract][Full Text] [Related]
35. The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. de Haan G; Dontje B; Engel C; Loeffler M; Nijhof W Blood; 1995 Oct; 86(8):2986-92. PubMed ID: 7579391 [TBL] [Abstract][Full Text] [Related]
36. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow. Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837 [TBL] [Abstract][Full Text] [Related]
37. Measurement of long-term culture initiating cells (LTC-ICs) using limiting dilution: comparison of endpoints and stromal support. Weaver A; Ryder WD; Testa NG Exp Hematol; 1997 Dec; 25(13):1333-8. PubMed ID: 9406992 [TBL] [Abstract][Full Text] [Related]
38. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941 [TBL] [Abstract][Full Text] [Related]
39. Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor. Triozzi PL; Tucker F; Benzies T; Balcerzak SP Bone Marrow Transplant; 1996 Jul; 18(1):47-52. PubMed ID: 8831995 [TBL] [Abstract][Full Text] [Related]
40. Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients. Goldman SC; Bracho F; Davenport V; Slack R; Areman E; Shen V; Lenarsky C; Weinthal J; Hughes R; Cairo MS J Pediatr Hematol Oncol; 2001; 23(5):300-5. PubMed ID: 11464987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]